APO Research

APO RESEARCH · REPORT

Tumor MRD Detection Products and Services

Selected research

Market Structure

Global Tumor MRD Detection Products and Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Tumor MRD Detection Products and Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Tumor MRD Detection Products and Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tumor MRD Detection Products and Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tumor MRD Detection Products and Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Tumor MRD Detection Products and Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tumor MRD Detection Products and Services include Natera, Guardant Health, SeraCare Life Sciences, Inc. (LGC), Adaptive Biotechnologies, Invitae(ArcherDX), Cergentis B.V., LexentBio(Foundation Medicine), Genecast and Genetron Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Tumor MRD Detection Products and Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tumor MRD Detection Products and Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tumor MRD Detection Products and Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Tumor MRD Detection Products and Services market size, projected growth trends, production technologies, key applications, and end-use industries.

Tumor MRD Detection Products and Services Segment by Company

Natera

Guardant Health

SeraCare Life Sciences, Inc. (LGC)

Adaptive Biotechnologies

Invitae(ArcherDX)

Cergentis B.V.

LexentBio(Foundation Medicine)

Genecast

Genetron Health

Acornmed

Shenzhen Neoimmune Co., Ltd.

Tung Tree Gene

Geneseeq

BGI Genomics

Burning Rock Biotech Limited

GenePlus

Tumor MRD Detection Products and Services Segment by Type

MRD Detection Products

In Vitro Diagnostic (IVD) Test Service

Tumor MRD Detection Products and Services Segment by Application

Lung Cancer

Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer)

Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer)

Urinary System Tumors (Bladder Cancer)

Central Nervous System Tumors

Soft Tissue and Bone Tumors

Thyroid Cancer and Melanoma

Tumor MRD Detection Products and Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor MRD Detection Products and Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tumor MRD Detection Products and Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor MRD Detection Products and Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Tumor MRD Detection Products and Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tumor MRD Detection Products and Services industry.

Chapter 3: Detailed analysis of Tumor MRD Detection Products and Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tumor MRD Detection Products and Servicesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tumor MRD Detection Products and Services Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of MRD Detection Products Table 3. Key Players of In Vitro Diagnostic (IVD) Test Service Table 4. Global Tumor MRD Detection Products and Services Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Lung Cancer Table 6. Key Players of Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer) Table 7. Key Players of Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer) Table 8. Key Players of Urinary System Tumors (Bladder Cancer) Table 9. Key Players of Central Nervous System Tumors Table 10. Key Players of Soft Tissue and Bone Tumors Table 11. Key Players of Thyroid Cancer and Melanoma Table 12. Global Tumor MRD Detection Products and Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Tumor MRD Detection Products and Services Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Tumor MRD Detection Products and Services Market Share by Region (2021-2026) Table 15. Global Tumor MRD Detection Products and Services Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Tumor MRD Detection Products and Services Market Share by Region (2027-2032) Table 17. Tumor MRD Detection Products and Services Industry Trends Table 18. Tumor MRD Detection Products and Services Industry Drivers Table 19. Tumor MRD Detection Products and Services Industry Opportunities and Challenges Table 20. Tumor MRD Detection Products and Services Industry Restraints Table 21. Global Tumor MRD Detection Products and Services Revenue by Company (US$ Million) & (2021-2026) Table 22. Global Tumor MRD Detection Products and Services Revenue Market Share by Company (2021-2026) Table 23. Global Tumor MRD Detection Products and Services Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 24. Global Tumor MRD Detection Products and Services Key Company Head Office and Area Served Table 25. Global Tumor MRD Detection Products and Services Company, Product Type & Application Table 26. Global Tumor MRD Detection Products and Services Company Establishment Date Table 27. Global Company Market Concentration Ratio (CR5 and HHI) Table 28. Global Tumor MRD Detection Products and Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 29. Global Tumor MRD Detection Products and Services Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Tumor MRD Detection Products and Services Market Size by Type (2021-2026) & (US$ Million) Table 31. Global Tumor MRD Detection Products and Services Market Size by Type (2027-2032) & (US$ Million) Table 32. Global Tumor MRD Detection Products and Services Revenue Market Share by Type (2021-2026) Table 33. Global Tumor MRD Detection Products and Services Revenue Market Share by Type (2027-2032) Table 34. Global Tumor MRD Detection Products and Services Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Tumor MRD Detection Products and Services Market Size by Application (2021-2026) & (US$ Million) Table 36. Global Tumor MRD Detection Products and Services Market Size by Application (2027-2032) & (US$ Million) Table 37. Global Tumor MRD Detection Products and Services Revenue Market Share by Application (2021-2026) Table 38. Global Tumor MRD Detection Products and Services Revenue Market Share by Application (2027-2032) Table 39. Natera Company Information Table 40. Natera Business Overview Table 41. Natera Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Natera Tumor MRD Detection Products and Services Product Portfolio Table 43. Natera Recent Development Table 44. Guardant Health Company Information Table 45. Guardant Health Business Overview Table 46. Guardant Health Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Guardant Health Tumor MRD Detection Products and Services Product Portfolio Table 48. Guardant Health Recent Development Table 49. SeraCare Life Sciences, Inc. (LGC) Company Information Table 50. SeraCare Life Sciences, Inc. (LGC) Business Overview Table 51. SeraCare Life Sciences, Inc. (LGC) Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. SeraCare Life Sciences, Inc. (LGC) Tumor MRD Detection Products and Services Product Portfolio Table 53. SeraCare Life Sciences, Inc. (LGC) Recent Development Table 54. Adaptive Biotechnologies Company Information Table 55. Adaptive Biotechnologies Business Overview Table 56. Adaptive Biotechnologies Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Adaptive Biotechnologies Tumor MRD Detection Products and Services Product Portfolio Table 58. Adaptive Biotechnologies Recent Development Table 59. Invitae(ArcherDX) Company Information Table 60. Invitae(ArcherDX) Business Overview Table 61. Invitae(ArcherDX) Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Invitae(ArcherDX) Tumor MRD Detection Products and Services Product Portfolio Table 63. Invitae(ArcherDX) Recent Development Table 64. Cergentis B.V. Company Information Table 65. Cergentis B.V. Business Overview Table 66. Cergentis B.V. Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Cergentis B.V. Tumor MRD Detection Products and Services Product Portfolio Table 68. Cergentis B.V. Recent Development Table 69. LexentBio(Foundation Medicine) Company Information Table 70. LexentBio(Foundation Medicine) Business Overview Table 71. LexentBio(Foundation Medicine) Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. LexentBio(Foundation Medicine) Tumor MRD Detection Products and Services Product Portfolio Table 73. LexentBio(Foundation Medicine) Recent Development Table 74. Genecast Company Information Table 75. Genecast Business Overview Table 76. Genecast Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Genecast Tumor MRD Detection Products and Services Product Portfolio Table 78. Genecast Recent Development Table 79. Genetron Health Company Information Table 80. Genetron Health Business Overview Table 81. Genetron Health Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Genetron Health Tumor MRD Detection Products and Services Product Portfolio Table 83. Genetron Health Recent Development Table 84. Acornmed Company Information Table 85. Acornmed Business Overview Table 86. Acornmed Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Acornmed Tumor MRD Detection Products and Services Product Portfolio Table 88. Acornmed Recent Development Table 89. Shenzhen Neoimmune Co., Ltd. Company Information Table 90. Shenzhen Neoimmune Co., Ltd. Business Overview Table 91. Shenzhen Neoimmune Co., Ltd. Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Shenzhen Neoimmune Co., Ltd. Tumor MRD Detection Products and Services Product Portfolio Table 93. Shenzhen Neoimmune Co., Ltd. Recent Development Table 94. Tung Tree Gene Company Information Table 95. Tung Tree Gene Business Overview Table 96. Tung Tree Gene Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Tung Tree Gene Tumor MRD Detection Products and Services Product Portfolio Table 98. Tung Tree Gene Recent Development Table 99. Geneseeq Company Information Table 100. Geneseeq Business Overview Table 101. Geneseeq Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Geneseeq Tumor MRD Detection Products and Services Product Portfolio Table 103. Geneseeq Recent Development Table 104. BGI Genomics Company Information Table 105. BGI Genomics Business Overview Table 106. BGI Genomics Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. BGI Genomics Tumor MRD Detection Products and Services Product Portfolio Table 108. BGI Genomics Recent Development Table 109. Burning Rock Biotech Limited Company Information Table 110. Burning Rock Biotech Limited Business Overview Table 111. Burning Rock Biotech Limited Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Burning Rock Biotech Limited Tumor MRD Detection Products and Services Product Portfolio Table 113. Burning Rock Biotech Limited Recent Development Table 114. GenePlus Company Information Table 115. GenePlus Business Overview Table 116. GenePlus Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. GenePlus Tumor MRD Detection Products and Services Product Portfolio Table 118. GenePlus Recent Development Table 119. North America Tumor MRD Detection Products and Services Market Size by Type (2021-2026) & (US$ Million) Table 120. North America Tumor MRD Detection Products and Services Market Size by Type (2027-2032) & (US$ Million) Table 121. North America Tumor MRD Detection Products and Services Market Size by Application (2021-2026) & (US$ Million) Table 122. North America Tumor MRD Detection Products and Services Market Size by Application (2027-2032) & (US$ Million) Table 123. North America Tumor MRD Detection Products and Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. North America Tumor MRD Detection Products and Services Market Size by Country (2021-2026) Table 125. North America Tumor MRD Detection Products and Services Market Size by Country (2027-2032) Table 126. Europe Tumor MRD Detection Products and Services Market Size by Type (2021-2026) & (US$ Million) Table 127. Europe Tumor MRD Detection Products and Services Market Size by Type (2027-2032) & (US$ Million) Table 128. Europe Tumor MRD Detection Products and Services Market Size by Application (2021-2026) & (US$ Million) Table 129. Europe Tumor MRD Detection Products and Services Market Size by Application (2027-2032) & (US$ Million) Table 130. Europe Tumor MRD Detection Products and Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Europe Tumor MRD Detection Products and Services Market Size by Country (2021-2026) Table 132. Europe Tumor MRD Detection Products and Services Market Size by Country (2027-2032) Table 133. China Tumor MRD Detection Products and Services Market Size by Type (2021-2026) & (US$ Million) Table 134. China Tumor MRD Detection Products and Services Market Size by Type (2027-2032) & (US$ Million) Table 135. China Tumor MRD Detection Products and Services Market Size by Application (2021-2026) & (US$ Million) Table 136. China Tumor MRD Detection Products and Services Market Size by Application (2027-2032) & (US$ Million) Table 137. Asia Tumor MRD Detection Products and Services Market Size by Type (2021-2026) & (US$ Million) Table 138. Asia Tumor MRD Detection Products and Services Market Size by Type (2027-2032) & (US$ Million) Table 139. Asia Tumor MRD Detection Products and Services Market Size by Application (2021-2026) & (US$ Million) Table 140. Asia Tumor MRD Detection Products and Services Market Size by Application (2027-2032) & (US$ Million) Table 141. Asia Tumor MRD Detection Products and Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Asia Tumor MRD Detection Products and Services Market Size by Country (2021-2026) Table 143. Asia Tumor MRD Detection Products and Services Market Size by Country (2027-2032) Table 144. South America, Middle East & Africa Tumor MRD Detection Products and Services Market Size by Type (2021-2026) & (US$ Million) Table 145. South America, Middle East & Africa Tumor MRD Detection Products and Services Market Size by Type (2027-2032) & (US$ Million) Table 146. South America, Middle East & Africa Tumor MRD Detection Products and Services Market Size by Application (2021-2026) & (US$ Million) Table 147. South America, Middle East & Africa Tumor MRD Detection Products and Services Market Size by Application (2027-2032) & (US$ Million) Table 148. South America, Middle East & Africa Tumor MRD Detection Products and Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. South America, Middle East & Africa Tumor MRD Detection Products and Services Market Size by Country (2021-2026) Table 150. South America, Middle East & Africa Tumor MRD Detection Products and Services Market Size by Country (2027-2032) Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Tumor MRD Detection Products and Services Product Image Figure 2. Global Tumor MRD Detection Products and Services Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Tumor MRD Detection Products and Services Market Share by Type: 2025 VS 2032 Figure 4. MRD Detection Products Image Figure 5. In Vitro Diagnostic (IVD) Test Service Image Figure 6. Global Tumor MRD Detection Products and Services Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Tumor MRD Detection Products and Services Market Share by Application: 2025 VS 2032 Figure 8. Lung Cancer Image Figure 9. Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer) Image Figure 10. Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer) Image Figure 11. Urinary System Tumors (Bladder Cancer) Image Figure 12. Central Nervous System Tumors Image Figure 13. Soft Tissue and Bone Tumors Image Figure 14. Thyroid Cancer and Melanoma Image Figure 15. Global Tumor MRD Detection Products and Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 17. Global Tumor MRD Detection Products and Services Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Tumor MRD Detection Products and Services Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Tumor MRD Detection Products and Services Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Tumor MRD Detection Products and Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Tumor MRD Detection Products and Services Revenue Market Share by Type (2021-2032) Figure 24. Global Tumor MRD Detection Products and Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Tumor MRD Detection Products and Services Revenue Market Share by Application (2021-2032) Figure 26. North America Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 27. North America Tumor MRD Detection Products and Services Market Share by Type (2021-2032) Figure 28. North America Tumor MRD Detection Products and Services Market Share by Application (2021-2032) Figure 29. North America Tumor MRD Detection Products and Services Market Share by Country (2021-2032) Figure 30. United States Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 31. Canada Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 33. Europe Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 34. Europe Tumor MRD Detection Products and Services Market Share by Type (2021-2032) Figure 35. Europe Tumor MRD Detection Products and Services Market Share by Application (2021-2032) Figure 36. Europe Tumor MRD Detection Products and Services Market Share by Country (2021-2032) Figure 37. Germany Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 38. France Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 40. Italy Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 41. Russia Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 43. China Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 44. China Tumor MRD Detection Products and Services Market Share by Type (2021-2032) Figure 45. China Tumor MRD Detection Products and Services Market Share by Application (2021-2032) Figure 46. Asia Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 47. Asia Tumor MRD Detection Products and Services Market Share by Type (2021-2032) Figure 48. Asia Tumor MRD Detection Products and Services Market Share by Application (2021-2032) Figure 49. Asia Tumor MRD Detection Products and Services Market Share by Country (2021-2032) Figure 50. Japan Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 54. India Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 55. Australia Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Tumor MRD Detection Products and Services Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Tumor MRD Detection Products and Services Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Tumor MRD Detection Products and Services Market Share by Country (2021-2032) Figure 60. Brazil Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 65. UAE Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 67. Chile Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • MRD Detection Products
  • In Vitro Diagnostic (IVD) Test Service
Applications
  • Lung Cancer
  • Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer)
  • Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer)
  • Urinary System Tumors (Bladder Cancer)
  • Central Nervous System Tumors
  • Soft Tissue and Bone Tumors
  • Thyroid Cancer and Melanoma
Companies covered
  • Natera
  • Guardant Health
  • SeraCare Life Sciences, Inc. (LGC)
  • Adaptive Biotechnologies
  • Invitae(ArcherDX)
  • Cergentis B.V.
  • LexentBio(Foundation Medicine)
  • Genecast
  • Genetron Health
  • Acornmed
  • Shenzhen Neoimmune Co., Ltd.
  • Tung Tree Gene
  • Geneseeq
  • BGI Genomics
  • Burning Rock Biotech Limited
  • GenePlus

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Tumor MRD Detection Products and Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 MRD Detection Products
  5. 1.2.3 In Vitro Diagnostic (IVD) Test Service
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Tumor MRD Detection Products and Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Lung Cancer
  9. 1.3.3 Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer)
  10. 1.3.4 Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer)
  11. 1.3.5 Urinary System Tumors (Bladder Cancer)
  12. 1.3.6 Central Nervous System Tumors
  13. 1.3.7 Soft Tissue and Bone Tumors
  14. 1.3.8 Thyroid Cancer and Melanoma
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Tumor MRD Detection Products and Services Growth Trends by Region
  17. 1.5.1 Global Tumor MRD Detection Products and Services Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Tumor MRD Detection Products and Services Market Size by Region (2021-2026)
  19. 1.5.3 Tumor MRD Detection Products and Services Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Tumor MRD Detection Products and Services Market Dynamics
  1. 2.1 Tumor MRD Detection Products and Services Industry Trends
  2. 2.2 Tumor MRD Detection Products and Services Industry Drivers
  3. 2.3 Tumor MRD Detection Products and Services Industry Opportunities and Challenges
  4. 2.4 Tumor MRD Detection Products and Services Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Tumor MRD Detection Products and Services Revenue by Company (2021-2026)
  2. 3.2 Global Tumor MRD Detection Products and Services Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Tumor MRD Detection Products and Services Key Company Head office and Area Served
  4. 3.4 Global Tumor MRD Detection Products and Services Company, Product Type & Application
  5. 3.5 Global Tumor MRD Detection Products and Services Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Tumor MRD Detection Products and Services Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Tumor MRD Detection Products and Services Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Tumor MRD Detection Products and Services Tier 1, Tier 2, and Tier 3
4 Tumor MRD Detection Products and Services Market by Type
  1. 4.1 Global Tumor MRD Detection Products and Services Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Tumor MRD Detection Products and Services Market Size by Type (2021-2032)
  3. 4.3 Global Tumor MRD Detection Products and Services Market Size Share by Type (2021-2032)
5 Tumor MRD Detection Products and Services Market by Application
  1. 5.1 Global Tumor MRD Detection Products and Services Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Tumor MRD Detection Products and Services Market Size by Application (2021-2032)
  3. 5.3 Global Tumor MRD Detection Products and Services Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Natera
  2. 6.1.1 Natera Company Information
  3. 6.1.2 Natera Business Overview
  4. 6.1.3 Natera Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Natera Tumor MRD Detection Products and Services Product Portfolio
  6. 6.1.5 Natera Recent Developments
  7. 6.2 Guardant Health
  8. 6.2.1 Guardant Health Company Information
  9. 6.2.2 Guardant Health Business Overview
  10. 6.2.3 Guardant Health Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Guardant Health Tumor MRD Detection Products and Services Product Portfolio
  12. 6.2.5 Guardant Health Recent Developments
  13. 6.3 SeraCare Life Sciences, Inc. (LGC)
  14. 6.3.1 SeraCare Life Sciences, Inc. (LGC) Company Information
  15. 6.3.2 SeraCare Life Sciences, Inc. (LGC) Business Overview
  16. 6.3.3 SeraCare Life Sciences, Inc. (LGC) Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 SeraCare Life Sciences, Inc. (LGC) Tumor MRD Detection Products and Services Product Portfolio
  18. 6.3.5 SeraCare Life Sciences, Inc. (LGC) Recent Developments
  19. 6.4 Adaptive Biotechnologies
  20. 6.4.1 Adaptive Biotechnologies Company Information
  21. 6.4.2 Adaptive Biotechnologies Business Overview
  22. 6.4.3 Adaptive Biotechnologies Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Adaptive Biotechnologies Tumor MRD Detection Products and Services Product Portfolio
  24. 6.4.5 Adaptive Biotechnologies Recent Developments
  25. 6.5 Invitae(ArcherDX)
  26. 6.5.1 Invitae(ArcherDX) Company Information
  27. 6.5.2 Invitae(ArcherDX) Business Overview
  28. 6.5.3 Invitae(ArcherDX) Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Invitae(ArcherDX) Tumor MRD Detection Products and Services Product Portfolio
  30. 6.5.5 Invitae(ArcherDX) Recent Developments
  31. 6.6 Cergentis B.V.
  32. 6.6.1 Cergentis B.V. Company Information
  33. 6.6.2 Cergentis B.V. Business Overview
  34. 6.6.3 Cergentis B.V. Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Cergentis B.V. Tumor MRD Detection Products and Services Product Portfolio
  36. 6.6.5 Cergentis B.V. Recent Developments
  37. 6.7 LexentBio(Foundation Medicine)
  38. 6.7.1 LexentBio(Foundation Medicine) Company Information
  39. 6.7.2 LexentBio(Foundation Medicine) Business Overview
  40. 6.7.3 LexentBio(Foundation Medicine) Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 LexentBio(Foundation Medicine) Tumor MRD Detection Products and Services Product Portfolio
  42. 6.7.5 LexentBio(Foundation Medicine) Recent Developments
  43. 6.8 Genecast
  44. 6.8.1 Genecast Company Information
  45. 6.8.2 Genecast Business Overview
  46. 6.8.3 Genecast Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Genecast Tumor MRD Detection Products and Services Product Portfolio
  48. 6.8.5 Genecast Recent Developments
  49. 6.9 Genetron Health
  50. 6.9.1 Genetron Health Company Information
  51. 6.9.2 Genetron Health Business Overview
  52. 6.9.3 Genetron Health Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Genetron Health Tumor MRD Detection Products and Services Product Portfolio
  54. 6.9.5 Genetron Health Recent Developments
  55. 6.10 Acornmed
  56. 6.10.1 Acornmed Company Information
  57. 6.10.2 Acornmed Business Overview
  58. 6.10.3 Acornmed Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Acornmed Tumor MRD Detection Products and Services Product Portfolio
  60. 6.10.5 Acornmed Recent Developments
  61. 6.11 Shenzhen Neoimmune Co., Ltd.
  62. 6.11.1 Shenzhen Neoimmune Co., Ltd. Company Information
  63. 6.11.2 Shenzhen Neoimmune Co., Ltd. Business Overview
  64. 6.11.3 Shenzhen Neoimmune Co., Ltd. Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Shenzhen Neoimmune Co., Ltd. Tumor MRD Detection Products and Services Product Portfolio
  66. 6.11.5 Shenzhen Neoimmune Co., Ltd. Recent Developments
  67. 6.12 Tung Tree Gene
  68. 6.12.1 Tung Tree Gene Company Information
  69. 6.12.2 Tung Tree Gene Business Overview
  70. 6.12.3 Tung Tree Gene Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Tung Tree Gene Tumor MRD Detection Products and Services Product Portfolio
  72. 6.12.5 Tung Tree Gene Recent Developments
  73. 6.13 Geneseeq
  74. 6.13.1 Geneseeq Company Information
  75. 6.13.2 Geneseeq Business Overview
  76. 6.13.3 Geneseeq Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Geneseeq Tumor MRD Detection Products and Services Product Portfolio
  78. 6.13.5 Geneseeq Recent Developments
  79. 6.14 BGI Genomics
  80. 6.14.1 BGI Genomics Company Information
  81. 6.14.2 BGI Genomics Business Overview
  82. 6.14.3 BGI Genomics Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 BGI Genomics Tumor MRD Detection Products and Services Product Portfolio
  84. 6.14.5 BGI Genomics Recent Developments
  85. 6.15 Burning Rock Biotech Limited
  86. 6.15.1 Burning Rock Biotech Limited Company Information
  87. 6.15.2 Burning Rock Biotech Limited Business Overview
  88. 6.15.3 Burning Rock Biotech Limited Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Burning Rock Biotech Limited Tumor MRD Detection Products and Services Product Portfolio
  90. 6.15.5 Burning Rock Biotech Limited Recent Developments
  91. 6.16 GenePlus
  92. 6.16.1 GenePlus Company Information
  93. 6.16.2 GenePlus Business Overview
  94. 6.16.3 GenePlus Tumor MRD Detection Products and Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 GenePlus Tumor MRD Detection Products and Services Product Portfolio
  96. 6.16.5 GenePlus Recent Developments
7 North America
  1. 7.1 North America Tumor MRD Detection Products and Services Market Size (2021-2032)
  2. 7.2 North America Tumor MRD Detection Products and Services Market Size by Type
  3. 7.2.1 North America Tumor MRD Detection Products and Services Market Size by Type (2021-2026)
  4. 7.2.2 North America Tumor MRD Detection Products and Services Market Size by Type (2027-2032)
  5. 7.2.3 North America Tumor MRD Detection Products and Services Market Share by Type (2021-2032)
  6. 7.3 North America Tumor MRD Detection Products and Services Market Size by Application
  7. 7.3.1 North America Tumor MRD Detection Products and Services Market Size by Application (2021-2026)
  8. 7.3.2 North America Tumor MRD Detection Products and Services Market Size by Application (2027-2032)
  9. 7.3.3 North America Tumor MRD Detection Products and Services Market Share by Application (2021-2032)
  10. 7.4 North America Tumor MRD Detection Products and Services Market Size by Country
  11. 7.4.1 North America Tumor MRD Detection Products and Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Tumor MRD Detection Products and Services Market Size by Country (2021-2026)
  13. 7.4.3 North America Tumor MRD Detection Products and Services Market Size by Country (2027-2032)
  14. 7.4.4 North America Tumor MRD Detection Products and Services Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Tumor MRD Detection Products and Services Market Size (2021-2032)
  2. 8.2 Europe Tumor MRD Detection Products and Services Market Size by Type
  3. 8.2.1 Europe Tumor MRD Detection Products and Services Market Size by Type (2021-2026)
  4. 8.2.2 Europe Tumor MRD Detection Products and Services Market Size by Type (2027-2032)
  5. 8.2.3 Europe Tumor MRD Detection Products and Services Market Share by Type (2021-2032)
  6. 8.3 Europe Tumor MRD Detection Products and Services Market Size by Application
  7. 8.3.1 Europe Tumor MRD Detection Products and Services Market Size by Application (2021-2026)
  8. 8.3.2 Europe Tumor MRD Detection Products and Services Market Size by Application (2027-2032)
  9. 8.3.3 Europe Tumor MRD Detection Products and Services Market Share by Application (2021-2032)
  10. 8.4 Europe Tumor MRD Detection Products and Services Market Size by Country
  11. 8.4.1 Europe Tumor MRD Detection Products and Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Tumor MRD Detection Products and Services Market Size by Country (2021-2026)
  13. 8.4.3 Europe Tumor MRD Detection Products and Services Market Size by Country (2027-2032)
  14. 8.4.4 Europe Tumor MRD Detection Products and Services Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Tumor MRD Detection Products and Services Market Size (2021-2032)
  2. 9.2 China Tumor MRD Detection Products and Services Market Size by Type
  3. 9.2.1 China Tumor MRD Detection Products and Services Market Size by Type (2021-2026)
  4. 9.2.2 China Tumor MRD Detection Products and Services Market Size by Type (2027-2032)
  5. 9.2.3 China Tumor MRD Detection Products and Services Market Share by Type (2021-2032)
  6. 9.3 China Tumor MRD Detection Products and Services Market Size by Application
  7. 9.3.1 China Tumor MRD Detection Products and Services Market Size by Application (2021-2026)
  8. 9.3.2 China Tumor MRD Detection Products and Services Market Size by Application (2027-2032)
  9. 9.3.3 China Tumor MRD Detection Products and Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Tumor MRD Detection Products and Services Market Size (2021-2032)
  2. 10.2 Asia Tumor MRD Detection Products and Services Market Size by Type
  3. 10.2.1 Asia Tumor MRD Detection Products and Services Market Size by Type (2021-2026)
  4. 10.2.2 Asia Tumor MRD Detection Products and Services Market Size by Type (2027-2032)
  5. 10.2.3 Asia Tumor MRD Detection Products and Services Market Share by Type (2021-2032)
  6. 10.3 Asia Tumor MRD Detection Products and Services Market Size by Application
  7. 10.3.1 Asia Tumor MRD Detection Products and Services Market Size by Application (2021-2026)
  8. 10.3.2 Asia Tumor MRD Detection Products and Services Market Size by Application (2027-2032)
  9. 10.3.3 Asia Tumor MRD Detection Products and Services Market Share by Application (2021-2032)
  10. 10.4 Asia Tumor MRD Detection Products and Services Market Size by Country
  11. 10.4.1 Asia Tumor MRD Detection Products and Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Tumor MRD Detection Products and Services Market Size by Country (2021-2026)
  13. 10.4.3 Asia Tumor MRD Detection Products and Services Market Size by Country (2027-2032)
  14. 10.4.4 Asia Tumor MRD Detection Products and Services Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Tumor MRD Detection Products and Services Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Tumor MRD Detection Products and Services Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Tumor MRD Detection Products and Services Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Tumor MRD Detection Products and Services Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Tumor MRD Detection Products and Services Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Tumor MRD Detection Products and Services Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Tumor MRD Detection Products and Services Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Tumor MRD Detection Products and Services Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Tumor MRD Detection Products and Services Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Tumor MRD Detection Products and Services Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Tumor MRD Detection Products and Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Tumor MRD Detection Products and Services Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Tumor MRD Detection Products and Services Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Tumor MRD Detection Products and Services Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research